NGSベースのRNAシーケンス市場 : 製品とサービス (サンプル調製、プラットフォームと消耗品、サービス、データ分析)、テクノロジー (SBS、SMRT、ナノポア)、用途(De Novo、エピジェネティクス、small RNA)、エンドユーザー、地域別 – 2027年までの世界予測
NGS-based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2027
世界のNGSベースのRNAシーケンス市場は2022年中に25億ドル、2027年までの55億ドルに達し、予測期間内の年平均成長率（CAGR）は17.2％になると予測されています。
MarketsandMarkets（マーケッツアンドマーケッツ）「NGSベースのRNAシーケンス市場 : 製品とサービス (サンプル調製、プラットフォームと消耗品、サービス、データ分析)、テクノロジー (SBS、SMRT、ナノポア)、用途(De Novo、エピジェネティクス、small RNA)、エンドユーザー、地域別 – 2027年までの世界予測 – NGS-based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2027」は世界の次世代シーケンシング（NGS）を用いたRNAシーケンス（RNA-Seq）市場における主要セグメント毎の調査・分析結果を提供します。
Report Overview
The global NGS-based RNA-sequencing market is projected to reach USD 5.5 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 17.2% during the forecast period.
Growth in the NGS-based RNA-sequencing market is mainly driven by the advantages of RNA sequencing over conventional technologies, the decreasing cost of genome sequencing, increasing government funding to support genomics projects, growing research involving RNA sequencing, growing cancer cases, the increasing application of NGS in cancer research, and rapid growth in personalized medicine. On the other hand, a lack of qualified specialists, end-user budget constraints in developing countries, and standardization concerns in diagnostic testing are expected to limit the market growth.
List of Companies Profiled in the Report
- Illumina, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- PerkinElmer, Inc. (US)
- QIAGEN N.V. (Netherlands)
- Eurofins Scientific (UK)
- Oxford Nanopore Technologies (UK)
- Agilent Technologies, Inc. (US)
- BGI Group (China)
- GENEWIZ (US)
- Hamilton Company (US)
- NuGEN Technologies (US)
- Psomagen, Inc. (South Korea)
- F. Hoffmann-La Roche AG (Switzerland)
- Takara Bio, Inc. (Japan)
- Pacific Biosciences (US)
- Zymo Research Corporation (US)
- Lucigen Corporation (US)
- Genotypic Technology (India)
- Oxford Gene Technology (UK)
- Becton, Dickinson and Company (US)